2014 Annual Meeting | 3ES.001 - Improving Accuracy of Dementia Diagnosis: Case Studies with Both Imaging and Neuropathology
09:00 AM - 09:15 AM |
Introduction and Process
James B. Leverenz, MD, FAAN |
|
09:15 AM - 09:35 AM |
Clinical Approach to a Patient with Dementia (Case Scenario I)
Edward Y. Zamrini, MD |
|
09:35 AM - 09:55 AM |
Using Imaging to Evaluate Dementia (Case Scenario I)
Norman L. Foster, MD, FAAN |
|
09:55 AM - 10:15 AM |
Tools for Evaluation of the Neuropathology of Dementia (Case Scenario I)
James B. Leverenz, MD, FAAN |
|
10:15 AM - 12:00 AM |
Additional Case Scenarios
|
James B. Leverenz, MD, FAAN | Dr. Leverenz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Leverenz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Leverenz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. |
Edward Y. Zamrini, MD | Dr. Zamrini has received personal compensation for serving as an employee of George Washington University. Dr. Zamrini has received personal compensation for serving as an employee of Irvine Clinical Research. Dr. Zamrini has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NIH. Dr. Zamrini has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Zamrini has received research support from NIH. The institution of Dr. Zamrini has received research support from NIH. |
Norman L. Foster, MD, FAAN | No disclosure on file |